Published in Cancer Weekly, April 21st, 1997
GTC's alliance with Astra AB, to identify and develop novel anti-infectives to treat H. pylori, began in September 1995. Initiation of high-throughput drug screening triggers a research milestone payment, the third research milestone achieved by GTC in the alliance.
"We are very pleased with the progress of our collaboration with Astra," stated Robert J. Hennessey,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.